Novel technology positions 'off-the-shelf' cancer immunotherapy for the clinic
UCLA scientists develop a new method to engineer immune cells that could treat multiple patients.
Source: ucla.edu
Stay updated with breaking news from Lili Yang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UCLA scientists develop a new method to engineer immune cells that could treat multiple patients.
The collaboration among researchers at UCLA, USC and Caltech will advance cell and tissue engineering technology
This article explores a feeder-cell alternative for scale-up induced pluripotent stem cell (iPSC) manufacturing.
Highlights from Marketplace Morning Report, Insider, CNBC and others.
UCLA scientists have developed a new method to engineer more powerful immune cells that can potentially be used for "off-the-shelf" cell therapy to treat challenging cancers.